4/A: USPH Director Corrects Stock Grant Price Filing

Director Anne Motsenbocker filed an amendment to correct the reported transaction price of a restricted stock grant from $61.61 to $0.00.

Summary

• Director Anne Motsenbocker received a grant of 2,306 shares of common stock.
• The filing corrects a clerical error from the original May 20, 2026, filing where the price was incorrectly listed as $61.61.
• The actual transaction price for the restricted stock grant is $0.00.
• The shares are subject to a vesting schedule with restrictions lapsing between August 2026 and March 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update with no impact on the company's fundamental outlook.

Positives

• The amendment demonstrates transparency and regulatory compliance by correcting a reporting error.

Negatives

• The initial filing contained a clerical error regarding the transaction price.

Risks

• None identified; this is a routine administrative correction.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that administrative amendments to insider filings are common and generally do not reflect changes in company strategy or financial health.

Comparison to Industry Standards

• The filing follows standard SEC reporting requirements for director compensation and equity disclosures.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors.

Next Steps

• Vesting of 1,153 shares on August 20, 2026.
• Vesting of 576 shares on November 20, 2026.
• Vesting of 577 shares on March 6, 2027.

Key Dates

Keywords

USPH, U.S. Physical Therapy, Director, Insider Trading, Form 4/A, Stock Incentive Plan